The FNIH Salutes Science Leading the Way

For more than a quarter century, the FNIH has contributed to significant progress in shaping the course of biomedical science and human health. We have catalyzed innovation and discovery by implementing collaborations and programs to answer the toughest scientific questions. Our initiatives have sped the development of new diagnostics, therapies, and cures. Through education, awards, and other projects, we have helped cultivate global thought leadership, propel scientific careers, and deliver high-quality patient care. At every step of the way, science has served as our beacon.

WHO Guidance Framework for Testing Genetically Modified Mosquitoes:

A collaboration with GeneConvene to update the 2014 guidance with current standards of quality and consistency for developing, testing, and regulating new genetic technologies to help stem the spread of vector-borne diseases.

Read More

Accelerating Medicines Partnership for the Bespoke Gene Therapy Consortium (AMP BGTC):

A public-private partnership to accelerate the delivery of promising new gene therapies to patients with rare diseases that currently lack effective treatments.

Read More

NIMBLE Project’s First Set of Data on Establishing Non-Invasive Biomarkers to Diagnose NASH:

The first data produced by this five-year program topline the suitability of candidate blood-based non-invasive biomarkers for use in clinical trials of treatments for Non-Alcoholic Steatohepatitis (NASH).

Read More

Kovler Foundation’s First Gift to the National Institute on Minority Health and Health Disparities:

The Judy and Peter Blum Kovler Foundation funds a fellowship supporting the Community Engagement Alliance (CEAL) Against COVID-19 Disparities.

Read More